Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs

Andrew Brown; E Davison; M M Sleeper

doi:10.1111/j.1939-1676.2010.0517.x

Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs

Andrew Brown, E Davison, M M Sleeper

Royal (Dick) School of Veterinary Studies

Research output: Contribution to journal › Article › peer-review

Abstract

Pulmonary arterial hypertension (PAH) in dogs carries a poor prognosis. Sildenafil increases exercise capacity and improves hemodynamics in people with PAH.

Original language	English
Pages (from-to)	850-4
Number of pages	5
Journal	Journal of Veterinary Internal Medicine
Volume	24
Issue number	4
DOIs	https://doi.org/10.1111/j.1939-1676.2010.0517.x
Publication status	Published - 2010

Keywords / Materials (for Non-textual outputs)

Animals
Cross-Over Studies
Dogs
Double-Blind Method
Female
Hypertension, Pulmonary
Male
Piperazines
Purines
Sulfones
Vasodilator Agents

Access to Document

10.1111/j.1939-1676.2010.0517.x

Cite this

@article{b77b8703d8e74483aced824e88f41ccd,

title = "Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs",

abstract = "Pulmonary arterial hypertension (PAH) in dogs carries a poor prognosis. Sildenafil increases exercise capacity and improves hemodynamics in people with PAH.",

keywords = "Animals, Cross-Over Studies, Dogs, Double-Blind Method, Female, Hypertension, Pulmonary, Male, Piperazines, Purines, Sulfones, Vasodilator Agents",

author = "Andrew Brown and E Davison and Sleeper, {M M}",

year = "2010",

doi = "10.1111/j.1939-1676.2010.0517.x",

language = "English",

volume = "24",

pages = "850--4",

journal = "Journal of Veterinary Internal Medicine",

issn = "0891-6640",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs

AU - Brown, Andrew

AU - Davison, E

AU - Sleeper, M M

PY - 2010

Y1 - 2010

N2 - Pulmonary arterial hypertension (PAH) in dogs carries a poor prognosis. Sildenafil increases exercise capacity and improves hemodynamics in people with PAH.

AB - Pulmonary arterial hypertension (PAH) in dogs carries a poor prognosis. Sildenafil increases exercise capacity and improves hemodynamics in people with PAH.

KW - Animals

KW - Cross-Over Studies

KW - Dogs

KW - Double-Blind Method

KW - Female

KW - Hypertension, Pulmonary

KW - Male

KW - Piperazines

KW - Purines

KW - Sulfones

KW - Vasodilator Agents

U2 - 10.1111/j.1939-1676.2010.0517.x

DO - 10.1111/j.1939-1676.2010.0517.x

M3 - Article

C2 - 20412435

SN - 0891-6640

VL - 24

SP - 850

EP - 854

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

IS - 4

ER -

Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this